Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Cortexin (CORT) is a research peptide, at the approved in russia stage in the published literature. Polypeptide complex from animal brain cortex used in Russia for neurological conditions.
Polypeptide complex from animal brain cortex used in Russia for neurological conditions.
| Research Status | Approved in Russia |
|---|---|
| Half-Life | Variable |
| Administration | Intramuscular injection |
| Doses Reported in Published Studies | 10 mg IM daily |
Neurotrophic and neuroprotective effects through multiple peptide components.
Polypeptide complex from animal brain cortex used in Russia for neurological conditions.
Neurotrophic and neuroprotective effects through multiple peptide components.
Cortexin is at the following stage in the published literature: Approved in Russia. All information is for research and educational purposes only.
Reported half-life: Variable.
Reported administration route in the literature: Intramuscular injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.